April 11, 2024

Vitamin K Market Size to Hit USD 2,126.08 Million by 2033

The global vitamin K market size surpassed USD 918.94 million in 2023 and is estimated to hit around USD 2,126.08 million by 2033, growing at a CAGR of 8.75% from 2024 to 2033.

Key Points

  • North America held the largest market share of 39% in 2023.
  • Asia Pacific is anticipated to witness the fastest rate of growth in the Vitamin K market during the forecast period.
  • By product type, the Vitamin K2 segment accounted for a considerable share and is observed to contribute a significant share in the upcoming period.
  • By application, the osteoporosis segment held a significant share of the market in 2023.
  • By application, the Vitamin K Deficiency Bleeding (VKDB) segment is expected to grow significantly during the forecast period.
  • By route of administration, the oral segment led the market with the largest share in 2023.

Vitamin K Market Size 2024 to 2033

The global Vitamin K market has experienced substantial growth in recent years, driven by increasing consumer awareness regarding the importance of Vitamin K in maintaining bone health, cardiovascular health, and overall well-being. Vitamin K is a fat-soluble vitamin that plays a crucial role in blood clotting, bone metabolism, and cardiovascular health. It exists in two main forms: Vitamin K1 (phylloquinone), primarily found in green leafy vegetables, and Vitamin K2 (menaquinone), which is synthesized by bacteria in the gut and found in fermented foods and animal products. The market for Vitamin K encompasses various products, including dietary supplements, fortified foods, and pharmaceuticals, catering to a diverse range of consumer needs and preferences.

Get a Sample: https://www.precedenceresearch.com/sample/3971

Growth Factors:

Several factors have contributed to the growth of the global Vitamin K market. Firstly, rising concerns about osteoporosis and bone health have fueled demand for Vitamin K supplements and fortified foods. Studies have shown that Vitamin K plays a crucial role in bone metabolism by facilitating the incorporation of calcium into bone tissue and inhibiting the breakdown of bone. As the aging population grows and the prevalence of osteoporosis increases, there is a growing awareness of the importance of Vitamin K in maintaining bone density and reducing the risk of fractures, driving demand for Vitamin K products.

Moreover, growing evidence supporting the role of Vitamin K in cardiovascular health has spurred interest in Vitamin K supplementation. Research suggests that Vitamin K2 may help prevent arterial calcification and reduce the risk of cardiovascular disease by activating proteins involved in calcium metabolism and preventing calcium deposition in blood vessels. As cardiovascular disease remains a leading cause of mortality worldwide, there is growing interest in Vitamin K as a potential preventive measure, driving demand for Vitamin K supplements and functional foods targeting cardiovascular health.

Additionally, changing dietary patterns and lifestyles have contributed to the increased prevalence of Vitamin K deficiency in certain populations. Modern diets often lack sufficient quantities of Vitamin K-rich foods, such as green leafy vegetables and fermented products, leading to suboptimal Vitamin K intake. Factors such as restrictive diets, digestive disorders, and antibiotic use can further exacerbate Vitamin K deficiency, highlighting the need for supplementation and fortification to ensure adequate Vitamin K intake among at-risk individuals.

Furthermore, advancements in food fortification technologies and the availability of innovative delivery formats have expanded the market for Vitamin K-fortified foods and beverages. Manufacturers are incorporating Vitamin K into a wide range of products, including dairy products, cereals, juices, and snacks, to enhance their nutritional profile and appeal to health-conscious consumers. The growing popularity of functional foods and beverages that offer targeted health benefits has further propelled the demand for Vitamin K-fortified products, driving market growth.

Region Insights:

The adoption of Vitamin K products varies across regions, influenced by factors such as dietary habits, healthcare infrastructure, and consumer awareness. In North America, the United States and Canada dominate the Vitamin K market, driven by high consumer awareness, a well-established dietary supplement industry, and robust healthcare systems. The growing aging population and increasing prevalence of chronic diseases such as osteoporosis and cardiovascular disease have fueled demand for Vitamin K supplements and fortified foods in the region.

In Europe, countries like Germany, the United Kingdom, and France are key markets for Vitamin K products, benefiting from a strong regulatory framework, widespread availability of fortified foods, and a growing emphasis on preventive healthcare. The European Food Safety Authority (EFSA) has approved health claims related to Vitamin K’s role in blood clotting and bone health, supporting the marketing and promotion of Vitamin K products in the region. Moreover, the popularity of functional foods and dietary supplements among health-conscious consumers has driven the demand for Vitamin K-fortified products in Europe.

In Asia Pacific, countries such as Japan, China, and South Korea are witnessing increasing demand for Vitamin K supplements and functional foods, driven by aging populations, rising healthcare expenditures, and growing awareness of preventive healthcare practices. In Japan, where the population is among the oldest in the world, there is a strong cultural emphasis on health and longevity, driving demand for dietary supplements targeting bone and cardiovascular health. Moreover, the growing middle-class population in emerging markets such as China and India presents significant growth opportunities for Vitamin K product manufacturers, as consumers become increasingly health-conscious and seek preventive healthcare solutions.

In Latin America and the Middle East/Africa regions, the Vitamin K market is relatively nascent but showing signs of growth, driven by improving healthcare infrastructure, rising disposable incomes, and increasing consumer awareness of preventive healthcare. As lifestyles become more sedentary, and dietary patterns shift towards processed and convenience foods, there is a growing need for nutritional supplementation to address micronutrient deficiencies, including Vitamin K. Manufacturers are tapping into these emerging markets by introducing Vitamin K supplements and fortified foods tailored to local preferences and dietary habits.

Vitamin K Market Scope

Report CoverageDetails
Growth Rate from 2024 to 2033CAGR of 8.75%
Global Market Size in 2023USD 918.94 Million
Global Market Size by 2033USD 2,126.08 Million
U.S. Market Size in 2023USD 250.87 Million
U.S. Market Size by 2033USD 580.42 Million
Base Year2023
Forecast Period2024 to 2033
Segments CoveredBy Product Type, By Route of Administration, and By Application
Regions CoveredNorth America, Europe, Asia-Pacific, Latin America, and Middle East & Africa

Vitamin K Market Dynamics


Several drivers are shaping the growth of the global Vitamin K market. Firstly, increasing consumer awareness of the health benefits of Vitamin K and its role in maintaining bone and cardiovascular health is driving demand for Vitamin K products. As consumers become more proactive about their health and seek preventive healthcare solutions, there is growing interest in dietary supplements and fortified foods that offer targeted nutritional support.

Moreover, the aging population demographic is a significant driver of Vitamin K market growth, particularly in regions with a large elderly population. As individuals age, the risk of osteoporosis, cardiovascular disease, and other age-related conditions increases, driving demand for Vitamin K supplements and functional foods aimed at preserving bone density and cardiovascular health. Manufacturers are targeting this demographic with products specifically formulated to meet the nutritional needs of older adults, including higher doses of Vitamin K and other micronutrients.

Furthermore, healthcare professionals’ recommendations and endorsements play a crucial role in driving consumer acceptance and adoption of Vitamin K products. Physicians, dietitians, and other healthcare providers are increasingly recognizing the importance of Vitamin K in promoting overall health and wellness, leading to greater incorporation of Vitamin K supplementation and fortification into clinical practice and dietary recommendations. Health education campaigns and awareness initiatives aimed at both healthcare professionals and consumers are further driving market growth by highlighting the benefits of Vitamin K and the risks of deficiency.

Additionally, the growing trend towards personalized nutrition and wellness is driving demand for customized Vitamin K formulations tailored to individual needs and preferences. Advances in nutrigenomics and biomarker testing enable consumers to assess their nutritional status and make informed decisions about supplementation, creating opportunities for personalized Vitamin K products targeting specific health concerns and genetic predispositions. Manufacturers are leveraging these advancements to develop innovative formulations and delivery systems that cater to diverse consumer needs and lifestyles, driving market expansion.

Furthermore, regulatory support and favorable policy frameworks are facilitating market growth by providing clarity and guidance to manufacturers and consumers. Regulatory agencies such as the U.S. Food and Drug Administration (FDA), the European Food Safety Authority (EFSA), and the Ministry of Health in various countries play a crucial role in evaluating the safety and efficacy of Vitamin K products and establishing health claims related to Vitamin K’s benefits. Clear labeling requirements and quality standards help build consumer trust and confidence in Vitamin K products, driving market growth and fostering innovation.


The global Vitamin K market presents a range of opportunities for stakeholders across the value chain. Firstly, there is significant untapped potential in emerging markets, where rising disposable incomes, changing dietary patterns, and increasing awareness of preventive healthcare are driving demand for nutritional supplements and fortified foods. Manufacturers can capitalize on these opportunities by expanding their presence in emerging markets and tailoring their product offerings to meet local preferences and needs.

Read Also: Pet Diabetes Care Devices Market Size, Report by 2033

Recent Developments

  • In October 2023, Smidge Small Batch Supplements announced the launch of grass-fed, Australian Emu Oil for real food vitamin K2. The company unveiled a new small-batch supplement to their premium, clean line product line that offers essential nutrients lacking in even the best whole foods diet.
  • In November 2023, Abbott announced the launch of the new PediaSure with Nutri-Pull System. The Nutri-Pull system is a unique combination of ingredients like vitamin K2, vitamin D, vitamin C, and casein phosphopeptides (CPPs), which help support catch-up growth amongst children through the absorption of key nutrients.
  • In June 2022, Balchem Corporation announced the acquisition of vitamin K2 player Kappa Bioscience. Balchem Corporation has signed a definitive agreement to acquire Norwegian Vitamin K2 supplier Kappa Bioscience AS for approximately US$340 million.

Vitamin K Market Companies

  • Lonza Group
  • Glanbia Plc
  • ADM
  • Farbest Brands
  • SternVitamin GmbH & Co. K.G.
  • Adisseo
  • Rabar Pty Ltd
  • DSM
  • Kappa Bioscience
  • Livealth Biopharma
  • NattoPharma
  • Amphastar Pharmaceuticals Inc.
  • NOW Foods
  • Pfizer Inc
  • Solgar Inc
  • Nexeo Solutions
  • Kyowa Hakko USA
  • Stason Pharmaceuticals
  • Asiamerica Ingredients
  • Amway
  • Bluestar Adisseo Co.
  • Atlantic Essential Products Inc.
  • Bactolac Pharmaceutical Inc.

Segments Covered in the Report

By Product Type

  • Vitamin K1
  • Vitamin K2

By Route of Administration

  • Oral
  • Topical
  • Parenteral

By Application

  • Osteoporosis
  • Vitamin K Dependent Clotting Factor Deficiency (VKCFD)
  • Prothrombin deficiency
  • Vitamin K Deficiency Bleeding (VKDB)
  • Dermal Application

By Geography

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://www.expresswebwire.com/

Blog: https://www.uswebwire.com/

Blog: https://www.dailytechbulletin.com/

Blog: https://www.autoindustrybulletin.com/